Virbac UK Veterinary
Caution, This content is for veterinary professionals.

Ypozane®

Face up to prostate problems

Ypozane® is a novel, non-invasive oral treatment containing osaterone acetate for Benign Prostate Hyperplasia in dogs – a condition which affects over 80% of entire dogs over the age of five

Prostate Hyperplasia is often difficult to diagnose until the disease has progressed to a marked increase of the size of the prostate gland.  The simple, once-daily, seven-day treatment has been shown to reduce prostate volume by 40% in just 14 days and show prolonged benefits for up to six months.

    

Product Features & Benefits: 

  • Available in four tablet strengths suitable for dogs weighing 3kg to 60kg

  • Simple effective course - given orally, with or without food, at 0.25 to 0.5mg/kg once daily for seven days

  • Conveniently packaged in packs of seven tablets: one box for one complete treatment course

  • Fast-acting, with 40% reduction of prostate volume within 2 weeks, and with the effects sustained for up to six months1

 

Presentations Available: 

  • 7 x 1.875mg tablets (3 – 7.5kg)
  • 7 x 3.75mg tablets (7.5 – 15kg)
  • 7 x 7.5mg tablets (15 – 30kg)
  • 7 x 15mg tablets (30 – 60kg)
 
1. O’Shea, J.D. (1962).  Studies on the canine prostate gland: factors influencing its size and weight, Journal of Comparative Pathology, 72, 321-331.
Related products